Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Glioma and Alzheimer's Disease.

Lehrer S.

J Alzheimers Dis Rep. 2018 Dec 14;2(1):213-218. doi: 10.3233/ADR-180084.

2.
3.

Survival and low-grade glioma: the emergence of genetic information.

Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M.

Neurosurg Focus. 2015 Jan;38(1):E6. doi: 10.3171/2014.10.FOCUS12367.

4.

Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.

Maxwell R, Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Bettegowda C, Jallo GI, Terezakis SA, Groves ML.

World Neurosurg. 2018 Nov;119:e1006-e1015. doi: 10.1016/j.wneu.2018.08.044. Epub 2018 Aug 20.

PMID:
30138731
5.

Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006.

Zada G, Bond AE, Wang YP, Giannotta SL, Deapen D.

World Neurosurg. 2012 Mar-Apr;77(3-4):518-24. doi: 10.1016/j.wneu.2011.05.051. Epub 2011 Nov 7.

PMID:
22120376
6.

Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.

Georgakis MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, Eser S, Taraszkiewicz Ł, Sekerija M, Žagar T, Antunes L, Zborovskaya A, Bastos J, Florea M, Coza D, Demetriou A, Agius D, Strahinja RM, Themistocleous M, Tolia M, Tzanis S, Alexiou GA, Papanikolaou PG, Nomikos P, Kantzanou M, Dessypris N, Pourtsidis A, Petridou ET.

Cancer. 2017 Nov 15;123(22):4458-4471. doi: 10.1002/cncr.30884. Epub 2017 Jul 14.

7.

Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.

Wang XQ, Tao BB, Li B, Wang XH, Zhang WC, Wan L, Hua XM, Li ST.

Oncotarget. 2016 Jan 19;7(3):2354-66. doi: 10.18632/oncotarget.6221.

8.

Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.

Efthymiou AG, Goate AM.

Mol Neurodegener. 2017 May 26;12(1):43. doi: 10.1186/s13024-017-0184-x. Review.

9.

Is mortality due to primary malignant brain and other central nervous system tumors decreasing?

Gittleman H, Kromer C, Ostrom QT, Blanda R, Russell J, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 Jun;133(2):265-275. doi: 10.1007/s11060-017-2449-1. Epub 2017 May 3.

PMID:
28470430
11.

Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis.

Jallo GI, Friedlander DR, Kelly PJ, Wisoff JH, Grumet M, Zagzag D.

Neurosurgery. 1997 Nov;41(5):1052-9.

PMID:
9361058
12.

Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Clin Neurol Neurosurg. 2018 Sep;172:112-115. doi: 10.1016/j.clineuro.2018.07.003. Epub 2018 Jul 5.

PMID:
29986195
13.

Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.

Zhang AS, Ostrom QT, Kruchko C, Rogers L, Peereboom DM, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):726-735. doi: 10.1093/neuonc/now252.

14.

Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.

Babu R, Bagley JH, Park JG, Friedman AH, Adamson C.

J Neurosurg. 2013 Aug;119(2):434-41. doi: 10.3171/2013.4.JNS122329. Epub 2013 May 10.

PMID:
23662821
15.

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.

Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao G.

Oncotarget. 2017 Feb 21;8(8):12695-12704. doi: 10.18632/oncotarget.8657.

16.

Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease?

Realmuto S, Cinturino A, Arnao V, Mazzola MA, Cupidi C, Aridon P, Ragonese P, Savettieri G, D'Amelio M.

J Alzheimers Dis. 2012;31(1):177-82. doi: 10.3233/JAD-2012-120184.

PMID:
22531415
17.

Boron neutron capture therapy. Clinical brain tumor studies.

Nakagawa Y, Hatanaka H.

J Neurooncol. 1997 May;33(1-2):105-15.

PMID:
9151228
18.

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS.

JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.

PMID:
29931168
19.

Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma.

Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa EG.

Cancer Control. 2004 May-Jun;11(3):174-80.

PMID:
15153841
20.

Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study.

Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AE, Barnholtz-Sloan JS.

J Neurosurg Spine. 2011 Jun;14(6):742-7. doi: 10.3171/2011.1.SPINE10351. Epub 2011 Mar 11.

Supplemental Content

Support Center